Type of Spiritual Experience
A description of the experience
Paliperidone - trade name Invega , also known as 9-hydroxyrisperidone, is an atypical antipsychotic.
Invega is an extended release formulation for once-daily dosing. Paliperidone palmitate (trade name Invega Sustenna named Xeplion in Europe and other countries) is a long-acting injectable formulation of paliperidone palmitoyl ester indicated for once-monthly injection. Chemically, paliperidone is one of many active metabolites of the older atypical antipsychotic risperidone . It is indicated for the acute and maintenance treatment of schizophrenia.
On May 18, 2015, a new formulation of paliperidone palmitate was approved by the FDA under the brand name Invega Trinza. A similar 3 -monthly injection of prolonged release suspension was approved in 2016 by the European Medicines Agency originally under the brand name Paliperidone Janssen, later renamed to Trevicta.